Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
20/05/2025 | UBS Group AG | 1306(L) | 12,781,100(L) | 462,166,213(L) 464,387,150(S) | 12.29 12.35 | |
19/05/2025 | UBS Group AG | 1305(L) | 148,944,620(L) | 474,250,103(L) 465,440,150(S) | 12.61 12.37 | |
16/05/2025 | UBS Group AG | 1305(L) | 20,836,628(L) | 463,523,580(L) 465,575,150(S) | 12.32 12.38 | |
15/05/2025 | UBS Group AG | 1306(L) | 158,785,020(L) | 463,494,079(L) 465,703,150(S) | 12.32 12.38 | |
13/05/2025 | UBS Group AG | 1305(L) | 158,123,120(L) | 484,289,585(L) 477,545,881(S) | 12.87 12.70 | |
12/05/2025 | UBS Group AG | 1306(L) | 150,951,776(L) | 473,142,041(L) 473,871,381(S) | 12.58 12.60 | |
07/05/2025 | UBS Group AG | 1305(L) | 157,800,417(L) | 469,676,353(L) 473,027,881(S) | 12.49 12.57 | |
05/05/2025 | UBS Group AG | 1306(L) | 157,192,708(L) | 468,837,056(L) 472,524,381(S) | 12.46 12.56 | |
28/04/2025 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Liu Dianbo | 1314(L) | +2,000,000(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | |
28/04/2025 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
28/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
22/04/2025 | Liu Dianbo | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Life Sciences Group Ltd | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Nelumbo Investments Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Ginkgo (PTC) Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Life Sciences Group Ltd | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Pharma Holdings Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Shorea LBG | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Shorea LBG | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Ginkgo (PTC) Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Nelumbo Investments Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Luye Pharma Holdings Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | Liu Dianbo | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
21/04/2025 | UBS Group AG | 1305(L) | 13,369,550(L) | 465,328,456(L) 464,873,640(S) | 12.37 12.36 | |
16/04/2025 | UBS Group AG | 1305(L) | 129,682,526(L) | 456,669,828(L) 463,472,105(S) | 12.14 12.32 | |
15/04/2025 | UBS Group AG | 1306(L) | 131,986,981(L) | 456,832,580(L) 463,053,391(S) | 12.14 12.31 | |
14/04/2025 | UBS Group AG | 1305(L) | 131,986,981(L) | 463,682,824(L) 469,465,634(S) | 12.33 12.48 | |
11/04/2025 | UBS Group AG | 1306(L) | 168,178,893(L) | 464,031,557(L) 469,480,810(S) | 12.34 12.48 | |
10/04/2025 | UBS Group AG | 1305(L) | 48,976,687(L) | 475,331,631(L) 469,563,967(S) | 12.64 12.48 | |
07/04/2025 | UBS Group AG | 1306(L) | 38,334,386(L) | 463,173,280(L) 466,873,915(S) | 12.31 12.41 | |
04/04/2025 | UBS Group AG | 1305(L) | 52,043,522(L) | 475,511,726(L) 472,610,255(S) | 12.64 12.56 | |
1 2 3 4 5 6 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 29/05/2025 10:12 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |